US 6040334
Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy
expired A61KA61K31/35A61K31/366
Quick answer
US patent 6040334 (Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Mar 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Mar 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/35, A61K31/366, A61P, A61P35/00